insights_auto
Why is TMO down 2.77%?
Dive Deeperchevron_right
TMO:NYSE
Thermo Fisher Scientific Inc
$669.54
arrow_downward
-2.77%(-19.04) 1D
$673.50
arrow_upward
+0.59% (+3.96)bedtimeAfter hours
Closed: Nov 20, 4:00:02 PM GMT-5 · USD
search
All symbols
No data
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TMO...
Open
$689.72
High
$692.00
Low
$667.94
Mkt. cap
248.08B
Avg. vol.
2.20M
Volume
2.36M
Dividend
0.28%
Quarterly dividend
$0.47
Ex-dividend date
Dec 15, 2026
P/E ratio
35.35
52-wk high
$727.56
52-wk low
$435.27
EPS
$18.94
Beta
0.84
Shares outstanding
370.52M
No. of employees
125K
Open
$689.72
High
$692.00
Low
$667.94
Mkt. cap
248.08B
Avg. vol.
2.20M
Volume
2.36M
Dividend
0.28%
Quarterly dividend
$0.47
Ex-dividend date
Dec 15, 2026
P/E ratio
35.35
52-wk high
$727.56
52-wk low
$435.27
EPS
$18.94
Beta
0.84
Shares outstanding
370.52M
No. of employees
125K
News stories
From web sources and news partners
MarketWatch
·
8 hours ago
Thermo Fisher Scientific Inc. stock outperforms market despite losses on the day
Zacks
·
14 hours ago
Thermo Fisher (TMO) Up 1.8% Since Last Earnings Report: Can It Continue?
Yahoo! Finance Canada
·
15 hours ago
Thermo Fisher (TMO) Up 1.8% Since Last Earnings Report: Can It Continue?
About Thermo Fisher Scientific Inc
CEO-
Employees125K
Founded1956
HeadquartersWaltham, Massachusetts, United States
SectorHealth Care
Industry-
Websitethermofisher.com
Analyst ratings
Based on 18 analysts giving stock ratings to TMO in the past 3 months
Strong buy
Buy
15
Hold
3
Sell
0
12-month forecast
Based on 18 Wall Street analysts offering 12 month price targets for TMO in the last 3 months.
Highest
Current $669.54
$830.00 (+23.97%)
Average
$763.00 (+13.96%)
Lowest
$650.00 (-2.92%)
Analyst | Recommendation | Action | Price target | Projected | Date |
|---|---|---|---|---|---|
Eve Burstein Bernstein | Hold | Maintained | $675.00 | +0.8% | 11/18/2026 |
Unknown Analyst Guggenheim | Buy | Reiterated | $740.00 | +10.5% | 11/02/2026 |
Luke Sergott Barclays | Buy | Maintained | $775.00 | +15.8% | 11/02/2026 |
David Toung Argus Research | Buy | Reiterated | $780.00 | +16.5% | 10/29/2026 |
Avantika Dhabaria Bank of America Securities | Buy | Maintained | $795.00 | +18.7% | 10/30/2026 |
Avantika Dhabaria Bank of America Securities | Buy | Maintained | $795.00 | +18.7% | 10/30/2026 |
Casey Woodring J.P. Morgan | Buy | Maintained | $820.00 | +22.5% | 10/22/2026 |
Patrick B Donnelly Citi | Buy | Maintained | $800.00 | +19.5% | 10/23/2026 |
Aristotelis Moutopoulos DZ BANK AG | Hold | Downgraded | $650.00 | -2.9% | 10/23/2026 |
Jill Wu CMB International Securities | Buy | Maintained | $800.00 | +19.5% | 10/23/2026 |
Michael Ryskin Bank of America Securities | Buy | Reiterated | $795.00 | +18.7% | 10/22/2026 |
Doug Schenkel UBS | Buy | Reiterated | $800.00 | +19.5% | 10/22/2026 |
Daniel Brennan TD Cowen | Buy | Reiterated | $810.00 | +21% | 10/22/2026 |
Evie Koslosky Goldman Sachs | Buy | Maintained | $830.00 | +24% | 10/21/2026 |
Dan Leonard RBC Capital | Hold | Reiterated | $730.00 | +9% | 10/22/2026 |
Daniel Arias Stifel Nicolaus | Buy | Maintained | $775.00 | +15.8% | 10/22/2026 |
Catherine Ramsey Schulte Robert W. Baird | Buy | Maintained | $756.00 | +12.9% | 10/22/2026 |
Kallum Titchmarsh Morgan Stanley | Buy | Reiterated | $730.00 | +9% | 10/13/2026 |
Justin Bowers Deutsche Bank | Buy | Reiterated | $720.00 | +7.5% | 09/25/2026 |
Unknown Analyst Goldman Sachs | Buy | Maintained | $780.00 | +16.5% | 09/20/2026 |
Evan Stampler Wells Fargo | Buy | Reiterated | $660.00 | -1.4% | 09/17/2026 |
Unknown Analyst UBS | Buy | Upgraded | $730.00 | +9% | 09/08/2026 |
Michael Luo CFA CLSA | Buy | Initiated | $748.00 | +11.7% | 09/03/2026 |
David Westenberg Piper Sandler | Hold | Maintained | $600.00 | -10.4% | 07/27/2026 |
Matt Larew William Blair | Buy | Maintained | - | - | 07/24/2026 |
Tycho Peterson Jefferies | Buy | Reiterated | $630.00 | -5.9% | 07/23/2026 |
Brandon Couillard Wells Fargo | Buy | Reiterated | $615.00 | -8.1% | 07/23/2026 |
Vijay Kumar Evercore ISI | Buy | Maintained | $570.00 | -14.9% | 07/06/2026 |
Sidharth Sahoo HSBC | Hold | Downgraded | $540.00 | -19.3% | 06/03/2026 |
Michael Polark Wolfe Research | Buy | Initiated | $535.00 | -20.1% | 06/01/2026 |
Unknown Analyst Jefferies | Buy | Maintained | $585.00 | -12.6% | 05/21/2026 |
Unknown Analyst RBC Capital | Hold | Initiated | $490.00 | -26.8% | 05/14/2026 |
Hans Engel Erste Group | Hold | Maintained | - | - | 05/05/2026 |
Bill Selesky Argus Research | Buy | Maintained | $560.00 | -16.4% | 04/30/2026 |
Unknown Analyst Argus Research | Buy | Maintained | $560.00 | -16.4% | 04/30/2026 |
Natalya Davies Rothschild & Co Redburn | Buy | Maintained | $620.00 | -7.4% | 04/17/2026 |
Last report
Oct 21, 2026
Fiscal period
Q3 2026
- Normalized EPS / Est. (USD)
- GAAP EPS / Est. (USD)
$6.68 / $6.40
+4.33%beat
arrow_upward
Revenue / Est. (USD)
12.14B / 11.95B
+1.56%beat
arrow_upward
Fiscal Q3 2026 earnings call
youtube_liveWaiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
- Quarterly
- Annual
All values in USD | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 |
|---|---|---|---|---|
Revenue | 12.22B | 11.00B | 11.99B | 12.14B |
Cost of goods sold | 7.17B | 6.56B | 7.08B | 7.00B |
Cost of revenue | 7.17B | 6.56B | 7.08B | 7.00B |
Research and development expenses | 356.00M | 336.00M | 364.00M | 348.00M |
Total research and development expenses | - | - | - | - |
Selling, general, and admin expenses | 2.24B | 2.14B | 2.30B | 2.34B |
Operating expense | 2.46B | 2.48B | 2.66B | 2.69B |
Total operating expenses | 9.63B | 9.04B | 9.74B | 9.69B |
Operating income | 2.59B | 1.97B | 2.25B | 2.45B |
Other non operating income | -32.00M | -15.00M | 13.00M | 6.00M |
EBT including unusual items | 2.12B | 1.73B | 1.91B | 2.08B |
EBT excluding unusual items | 2.44B | 1.83B | 2.05B | 2.28B |
Income tax expense | 153.00M | 70.00M | 167.00M | 352.00M |
Effective tax rate | 7.21% | 4.06% | 8.75% | 16.93% |
Other operating expenses | -135.00M | 1.00M | - | - |
Net income | 1.96B | 1.65B | 1.74B | 1.72B |
Net profit margin | 16.08% | 15.00% | 14.47% | 14.18% |
Earnings per share | 6.57 | 5.44 | 6.03 | 6.68 |
Interest and investment income | 258.00M | 233.00M | 207.00M | 252.00M |
Interest expense | -365.00M | -354.00M | -401.00M | -417.00M |
Net interest expenses | -107.00M | -121.00M | -194.00M | -165.00M |
Depreciation and amortization charges | - | - | - | - |
EBITDA | 3.31B | 2.70B | 3.07B | 3.28B |
Gain or loss from assets sale | - | - | - | - |
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider | Position | Type | Date | Shares | Amount |
|---|---|---|---|---|---|
Page 1
Upcoming events